The Jewish Business News website ranks the research of Professor Michael Glickman and Dr. Inbal Maniv from the Faculty of Biology, featuring new discoveries about the development of Alzheimer’s disease, as one of the top seven major medical breakthroughs in Israel for 2023.
The researchers made a breakthrough in understanding the onset of sporadic Alzheimer’s Disease; they uncovered the mechanism that causes the accumulation of proteins involved in the disease’s development. Sporadic Alzheimer’s Disease is the most common form, occurring in people with no family members who have suffered from it as well. The study of Alzheimer’s Disease was led by Professor Michael Glickman and Dr. Inbal Maniv from the Faculty of Biology at the Technion and their results were Published in Nature Communications.
The research involved Mahasen Sarji, Anwar Badarna, Dr. Yaron Fuchs, and additional researchers from the Technion, in collaboration with researchers from Tel Aviv University, Maastricht University in the Netherlands, and the University of Glasgow in Scotland. The research was supported by the National Science Foundation, the philanthropic Schmidt Futures Foundation, and the BIRAX and Alzheimer Society partnerships.
